OPTIMA do Brasil invites to its Barrier Technology Seminar

OdB_OPTIMA do Brasil_Barrier Technology Seminar (P000802116)
In Optima Pharma and Metall+Plastic, pharmaceutical companies in South America have two experienced partners when it comes to upgrading existing plants or purchasing barrier technologies.
The event is being held because of the new Anvisa regulations on the use of barrier systems

Optima do Brasil is holding a Barrier Technology Seminar on March 11 and 12 in Vinhedo (São Paulo). The reason for this is the new regulations issued by the Brazilian health monitoring authority Anvisa on the use of barrier systems in pharmaceutical manufacturing. In specialist presentations, experts from Optima Pharma and Metall+Plastic will be providing information on barrier technologies such as isolators and RABS systems. The subjects of "Technology", "Project Handling" and "Real Application" will be discussed in depth in six workshops. Both companies have many years' experience in the fields of barrier technologies and filling technologies for pharmaceutical products.

"The Barrier Technology Seminar means we can provide our customers with the ideal platform, both for obtaining up-to-date information on the new Anivsa regulations and for familiarizing themselves with the latest barrier technologies," says Rolf Geissinger, Managing Director of Optima do Brasil. The seminar, which can be attended on March 11 or 12, covers all the information needed to prepare early for the new Anvisa regulations' requirements. The "RDC 301" regulation requires pharmaceutical companies to use barrier systems such as isolators or RABS to avoid contamination of the products.

OPTIMA MultiUse Filler and Isolator

Barrier technologies are indispensable in safe sterile manufacturing. Depending on the customer's circumstances, either RABS or isolators are the right solution.

DECOpulse® Bio-Dekontaminationsanlage

Among other things, the workshops will cover DECOpulse® – a bio-decontamination system that reduces previous cycle times. Metall+Plastic was awarded the Biotech Innovation Award 2019 for this new development.

Two days full of information and insights

In addition to specialist presentations on Anvisa regulation and the principles of barrier technology, the program will include six workshops in three different areas. The topic of "Technology" covers the introduction of products into the isolator or the RABS system. Matthias Aster, Team Leader Sales at Metall+Plastic, will be providing information about available isolator technologies. In the second unit of the workshop, experts will discuss how Optima Pharma's CSPE process cuts time-to-market. This is particularly important for pharma companies in South America: Using a project example, visitors will also learn how existing filling systems can be upgraded with RABS. The course ends with workshops on handling and cleaning from operating staff as well as procedures for bio-decontamination.

OPTIMA pharma and METALL+PLASTIC advise visitors to the Barrier Technology Seminar

Optima Pharma and Metall+Plastic provide support for upgrading existing filling lines or investment in new barrier systems. Metall+Plastic is a subsidiary of the Optima Pharma Division and has over 60 years of experience in the design, manufacturing, installation, qualification and validation of custom-made isolators. Metall+Plastic's achievements include the new STISO sterility test isolator and the award-winning DECOpulse® bio-decontamination system. Pharmaceutical filling and closing processes are designed and implemented as turnkey solutions in cooperation with Optima Pharma, including all upstream and downstream components.

Press release
Text and Image (.ZIP, 7.7 MB)
Denise Fiedler and Julia Völker
Do you have any questions? Please feel free to contact us.
Denise Fiedler and Julia Völker
Team Group Communication
+49 791 506-1472 pr-group@optima-packaging.comWrite e-mail
Denise Fiedler and Julia Völker
Denise Fiedler and Julia Völker
Team Group Communication
© 2024 OPTIMA. All rights reserved.
loading ...